-
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon
30 Apr 2024 18:11 GMT
… are no drugs currently available for the treatment of RSV … Nirsevimab (Beyfortus, Astrazeneca), and palivizumab (Synagis, Sobi, Inc.) … successful clinical trials or a successful pharmaceutical product.
This … the Committee for Medicinal Products for Human Use …
-
'We let bureaucracy get in the way of common sense': Call for faster appraisal of new RSV treatment
26 Mar 2024 11:21 GMT
… of a new preventative treatment for RSV (respiratory syncytial … antibody treatment has been approved by the European Medicines Agency … infants can be given Palivizumab which is a monoclonal … available it should “replace” Palivizumab for eligible babies and …
-
Drug Trials Snapshots: BEYFORTUS
15 Feb 2024 17:30 GMT
… trials that supported the original FDA approval of this drug, … to make decisions regarding medical care. Always speak … blind, active (palivizumab)-controlled, multicenter trial to evaluate the … Treatment Group, Trials 03 and 04
Demographic
Trial 03
Trial 04 …
-
Drug repurposing study finds lonafarnib effective against RSV
12 Feb 2024 00:49 GMT
… infections.
RSV infection treatment is currently symptomatic. … efficacious in patients. Palivizumab provides prophylaxis but is … in phase III clinical trials for hepatitis delta … for RSV treatment, highlighting the utility of drug-repurposing studies …
-
RSV immunizations not linked to deaths in clinical trial | Fact check
09 Feb 2024 16:05 GMT
… RSV treatment killed 12 infants in a clinical trial
A … RSV treatment.
"Despite 12 Deaths During Clinical Trials, CDC … Food and Drug Administration, which oversees clinical trials.
Infant … received palivizumab, a monoclonal antibody that the FDA had …
-
Palivizumab biosimilar by Mabxience Holding for Respiratory Syncytial Virus (RSV) Infections: Likelihood of Approval
04 Jan 2024 18:41 GMT
… Insud Pharma, is a biotechnology company specialized in the research … and cancers; bevacizumab, a medication targeting cancers and eye … complete picture of Palivizumab biosimilar’s drug-specific PTSR and … on GlobalData’s Pharmaceutical Intelligence Center.
-
Intranasal Palivizumab Fails to Prevent RSV Infection in Preterm Babies
04 Jan 2024 13:44 GMT
… randomized placebo-controlled trial found that daily intranasal palivizumab, a mucosal monoclonal … the efficacy of intranasal palivizumab for preventing RSV infection … Schuurman, R. (2023). Daily intranasal palivizumab to prevent respiratory syncytial virus …
-
The New RSV Drug Keeps Babies Out of the Hospital
27 Dec 2023 23:12 GMT
… New England Journal of Medicine, researchers report encouraging … that show how effective the drug treatment, nirsevimab (brand name: … an older, existing RSV treatment called palivizumab (brand name: Synagis). … RSV season, so doctors and parents were hoping …
-
New antibody treatment for RSV in infants highly effective in reducing hospitalisations
28 Dec 2023 14:06 GMT
… the babies who received the treatment, only 11 (0.3 … bronchiolitis and pneumonia.
The trial shows nirsevimab reduced likelihood of … child health and outbreak medicine at the University of … replaces a preventive antibody [palivizumab or Synagis] that has been …
-
In Response to Shortage, CDC, FDA Accelerate Release of RSV Shots for Infants
20 Nov 2023 10:28 GMT
… be distributed immediately to doctors and hospitals through the … has far exceeded supply, drug maker Sanofi said late … and infants with underlying medical conditions that place them … shot available, called Synagis (palivizumab), and the American Academy of …